Search

Jaymin H Shah

from San Jose, CA
Age ~44
Get Report
Also known as:
Jaymin N Shah
Related to:
Bhavin H Shah, 46Ranjit ShahDhara ShahSamir N Shah, 47Paulomi Shah, 45Sheetalkumar Shah, 42
Connected to:
Aadil Shah, 28Aalay D Shah, 32Aamer B Shah, 44Aashiv A Shah, 41Aasim Shah, 55Abdul R Shah, 58Abha H Shah, 52Abida Shah, 66Abu M Shah, 59Aftab H Shah, 66

Jaymin Shah Phones & Addresses

  • San Jose, CA
  • Sunnyvale, CA
  • Allen, TX
  • 7575 Frankford Rd, Dallas, TX 75252 (214) 377-8978
  • 2600 Waterview Pl, Richardson, TX 75080 (972) 231-2868
  • Northridge, CA
  • 2600 Waterview Pkwy, Richardson, TX 75080 (972) 231-2868

Work

Position: Building and Grounds Cleaning and Maintenance Occupations

Emails

j***[email protected]

Professional Records

Medicine Doctors

Jaymin Shah Photo 1

Jaymin R. Shah

View page
Specialties:
Anesthesiology
Education:
Medical School
Midwestern University/ Chicago College of Osteopathic Medicine
Graduated: 2005
Procedures:
Arthrocentesis
Osteopathic Manipulative Treatment
Conditions:
Ankylosing Spondylitis (AS)
Anxiety Phobic Disorders
Diabetes Mellitus (DM)
Disorders of Lipoid Metabolism
Fractures, Dislocations, Derangement, and Sprains
Description:
Dr. Shah graduated from the Midwestern University/ Chicago College of Osteopathic Medicine in 2005. He works in Janesville, WI and specializes in Anesthesiology. Dr. Shah is affiliated with Mercy Hospital & Trauma Center and Mercy Walworth Hospital & Medical Center.

Resumes

Resumes

Jaymin Shah Photo 2

Senior Application Consultant - Java Full Stack

View page
Location:
Sunnyvale, CA
Industry:
Information Technology And Services
Work:
Sirius Xm Radio Inc.
Senior Application Consultant - Java Full Stack
Major League Baseball Oct 2016 - Jun 2017
Software Engineer - Java
Unitedhealth Group Jan 2016 - Oct 2016
Software Engineer
One Advanced May 2012 - Oct 2015
Senior Software Engineer - Java Practice
Nihilent Technologies Jun 2010 - May 2012
System Analyst
Education:
Harrisburg University of Science and Technology 2015 - 2017
Master of Science, Masters, Management, Engineering Gujarat University 2003 - 2007
Bachelor of Engineering, Bachelors
Skills:
Java
Javascript
Java Enterprise Edition
Sql
Web Services
Sdlc
Jsp
Requirements Analysis
Html 5
Hibernate
Xml
Ajax
Oracle
Servlets
Ejb
Databases
Mysql
Agile Methodologies
Software Development
Struts
Software Project Management
Tomcat
Eclipse
Spring Framework
Jdbc
Jsf
Json
Css
Spring
Soa
Scrum
Subversion
Design Patterns
Oop
Ant
Mvc
Jquery
Core Java
Web Development
Pl/Sql
Html5
Cascading Style Sheets
Javaserver Pages
Dojo
Dhtmlx
Linux System Administration
Jboss Application Server
Ireport
Drools
Interests:
Children
Environment
Science and Technology
Disaster and Humanitarian Relief
Human Rights
Animal Welfare
Arts and Culture
Health
Languages:
English
Hindi
Gujarati
Jaymin Shah Photo 3

Technical Lead Level

View page
Location:
San Jose, CA
Industry:
Information Technology And Services
Work:
Einfochips
Technical Lead Level
Education:
Gujarat University 2003 - 2006
Bachelors, Bachelor of Science, Chemistry Gujarat University 2003 - 2006
Masters, Computer Science, Computer Applications, Computer Application Rachana High School 1985 - 1997
Skills:
Web Services
Asp.net
Microsoft Sql Server
Testing
Visual Studio
Databases
Java
Xml
Manual Testing
Core Java
C++
C
Sdlc
Web Applications
.Net
Software Development Life Cycle
.Net Framework
Interests:
Science and Technology
Environment
Children
Education
Jaymin Shah Photo 4

Executive Director, Clinical Pharmacology

View page
Location:
Berkeley, CA
Industry:
Pharmaceuticals
Work:
Gilead Sciences 2002 - 2006
Senior Director, Clinical Pharmacology
Durect Corporation 2002 - 2006
Executive Director, Clinical Pharmacology
Elan 1999 - 2002
Senior Director, Clinical Pharmacology
Alza Corporation 1995 - 1999
Associate Director, Clinical Pharmacology
Syntex Research 1988 - 1995
Scientist
Education:
University of Missouri - Kansas City 1983 - 1988
Doctorates, Doctor of Philosophy Virginia Commonwealth University 1981 - 1983
Karnataka Law College, Dharwad 1976 - 1980
Bachelors, Bachelor of Pharmacy, Pharmacy
Skills:
Clinical Pharmacology
Jaymin Shah Photo 5

Jaymin Shah

View page
Jaymin Shah Photo 6

Jaymin Shah

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Jaymin Shah
President
JANAK CORPORATION
1092 The Dalles, Sunnyvale, CA 94087

Publications

Us Patents

Method For Increasing The Bioavailability Of Metaxalone

View page
US Patent:
6407128, Jun 18, 2002
Filed:
Dec 3, 2001
Appl. No.:
09/998206
Inventors:
Michael Scaife - Poway CA
Jaymin Shah - Sunnyvale CA
Assignee:
Elan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A61K 3142
US Classification:
514376
Abstract:
A method of increasing the bioavailability of metaxalone by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of metaxalone in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.

Methods Of Using Metaxalone In The Treatment Of Musculoskeletal Conditions

View page
US Patent:
6683102, Jan 27, 2004
Filed:
Mar 25, 2002
Appl. No.:
10/104044
Inventors:
Michael Scaife - Poway CA, 92064
Jaymin Shah - Sunnyvale CA, 94086
Assignee:
Elan Pharmaceuticals, Inc. - South San Francisco GA
International Classification:
A61K 3142
US Classification:
514376
Abstract:
A method of increasing the bioavailability of metaxalone by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of metaxalone in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.

Transoral Dosage Forms Comprising Sufentanil And Naloxone

View page
US Patent:
20100010031, Jan 14, 2010
Filed:
Feb 8, 2008
Appl. No.:
12/449292
Inventors:
Su Yum, II - Los Altos CA, US
Jaymin Shah - Sunnyvale CA, US
Sung Yun Kwon - Fremont CA, US
Xiaoping Song - San Jose CA, US
International Classification:
A61K 31/4535
A61K 31/485
US Classification:
514282, 514326
Abstract:
The invention pertains to methods that include administering to a subject a transoral dosage form comprising a pharmaceutical carrier and sufentanil, and maintaining a mean pH ranging from about 3.5 to about 5.5 during a dosing period after administration of the transoral dosage form as determined using an in vitro donor media test. Related dosage forms are also disclosed. Also disclosed are transoral dosage forms and related methods, wherein a transoral dosage form may comprise: (1) about 5 to about 1000 micrograms of sufentanil; (2) about 50 micrograms to about 100 milligrams of naloxone; and (3) acidifying material in an amount sufficient to provide a mean pH ranging from about 3.5 to about 5.5 during a dosing period after administration of the transoral dosage form as determined using an in vitro donor media test; wherein the dosing period begins no earlier than about 1 minute after administration of the transoral dosage form, and ends no later than about 120 minutes after administration of the transoral dosage form.

Oral Pharmaceutical Dosage Forms

View page
US Patent:
20100260844, Oct 14, 2010
Filed:
Nov 3, 2009
Appl. No.:
12/590195
Inventors:
Jan J. Scicinski - Sunnyvale CA, US
William W. van Osdol - Mountain View CA, US
Michael H. Arenberg - Campbell CA, US
Jaymin Shah - Sunnyvale CA, US
International Classification:
A61K 31/445
A61K 9/00
A61P 25/00
US Classification:
424484, 514317
Abstract:
Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.

Oral Pharmaceutical Dosage Forms

View page
US Patent:
20140011842, Jan 9, 2014
Filed:
Jun 21, 2013
Appl. No.:
13/924232
Inventors:
William W. van Osdol - Mountain View CA, US
Michael H. Arenberg - Campbell CA, US
Jaymin Shah - Sunnyvale CA, US
International Classification:
A61K 31/4458
A61K 9/00
US Classification:
514317
Abstract:
Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.

Transoral Dosage Forms Comprising Sufentanil And Naloxone

View page
US Patent:
20200281915, Sep 10, 2020
Filed:
Feb 13, 2020
Appl. No.:
16/790207
Inventors:
- Cupertino CA, US
Jaymin Shah - Sunnyvale CA, US
Sung Yun Kwon - Fremont CA, US
Xiaoping Song - Saratoga CA, US
International Classification:
A61K 31/4535
A61K 9/00
A61K 9/06
A61K 31/485
Abstract:
The invention pertains to methods that include administering to a subject a transoral dosage form comprising a pharmaceutical carrier and sufentanil, and maintaining a mean pH ranging from about 3.5 to about 5.5 during a dosing period after administration of the transoral dosage form as determined using an in vitro donor media test. Related dosage forms are also disclosed. Also disclosed are transoral dosage forms and related methods, wherein a transoral dosage form may comprise: (1) about 5 to about 1000 micrograms of sufentanil; (2) about 50 micrograms to about 100 milligrams of naloxone; and (3) acidifying material in an amount sufficient to provide a mean pH ranging from about 3.5 to about 5.5 during a dosing period after administration of the transoral dosage form as determined using an in vitro donor media test; wherein the dosing period begins no earlier than about 1 minute after administration of the transoral dosage form, and ends no later than about 120 minutes after administration of the transoral dosage form.

Oral Pharmaceutical Dosage Forms

View page
US Patent:
20200000791, Jan 2, 2020
Filed:
May 7, 2019
Appl. No.:
16/405902
Inventors:
- Cupertino CA, US
William W. van Osdol - Mountain View CA, US
Huey-Ching Su - San Jose CA, US
Michael H. Arenberg - Campbell CA, US
Jaymin Shah - Sunnyvale CA, US
International Classification:
A61K 31/4458
A61K 9/16
A61K 9/48
A61K 9/50
A61K 9/00
Abstract:
Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.

Transoral Dosage Forms Comprising Sufentanil And Naloxone

View page
US Patent:
20180228792, Aug 16, 2018
Filed:
Jan 12, 2018
Appl. No.:
15/870625
Inventors:
- Cupertino CA, US
Jaymin Shah - Sunnyvale CA, US
Sung Yun Kwon - Fremont CA, US
Xiaoping Song - Saratoga CA, US
Assignee:
Durect Corporation - Cupertino CA
International Classification:
A61K 31/4535
A61K 31/485
A61K 9/06
A61K 9/00
A61K 9/70
A61K 9/20
Abstract:
The invention pertains to methods that include administering to a subject a transoral dosage form comprising a pharmaceutical carrier and sufentanil, and maintaining a mean pH ranging from about 3.5 to about 5.5 during a dosing period after administration of the transoral dosage form as determined using an in vitro donor media test. Related dosage forms are also disclosed. Also disclosed are transoral dosage forms and related methods, wherein a transoral dosage form may comprise: (1) about 5 to about 1000 micrograms of sufentanil; (2) about 50 micrograms to about 100 milligrams of naloxone; and (3) acidifying material in an amount sufficient to provide a mean pH ranging from about 3.5 to about 5.5 during a dosing period after administration of the transoral dosage form as determined using an in vitro donor media test; wherein the dosing period begins no earlier than about 1 minute after administration of the transoral dosage form, and ends no later than about 120 minutes after administration of the transoral dosage form.
Control profile
Jaymin H Shah from San Jose, CA, age ~44 Get Report